The Filing Desk

Nature's Sunshine Products

NATR · Nasdaq · Consumer Staples · Financials, fiscal 2016 to 2025

NATR · Last close · November 13, 2026
$10.36
Value Nature's Sunshine Products yourself

Nature's Sunshine Products' revenue rose 5.7% to $480 million in fiscal 2025. Its operating margin was 5.2%, up from 4.4% a year earlier. Free cash flow was $29 million, up 101.3%. It paid out $16 million in dividends and buybacks, 57% of free cash flow. The diluted share count fell 3.2%.

NATURE’S SUNSHINE PRODUCTS, INC. Latest fiscal year ended December 31, 2025 10-K filed March 10, 2026 · 0001628280-26-016540 Updated
Revenue
$480M
5.7%
Operating margin
5.2%
0.7 pts
Net income
$20M
153.7%
Free cash flow
$29M
101.3%
Return on capital
23.6%
10.5 pts
Market cap
$185M
Nov 13 close
P/E
12.6x
On $0.82 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Nature's Sunshine Products does

Nature's Sunshine Products makes and sells herbal and other nutritional supplements and personal care products. Its line of over 800 products covers general health, immune, heart, digestive and weight management products, and items such as aloe vera gel, shampoo and toothpaste. It buys herbs and other raw materials in bulk, then tests, formulates, packages and ships them. Most products are made at its plant in Spanish Fork, Utah, and contract manufacturers make some.

It sells through direct selling: independent consultants who use the products themselves or resell them to consumers, under the Nature's Sunshine Products and Synergy WorldWide brands. It pays these consultants commissions, which it calls volume incentives, based on their own sales and those of their sales organization. It reports four segments by region: Asia, Europe, North America, and Latin America and Other.

The 10-K says that in some markets a significant amount of revenue depends on only a few consultants and their large sales networks. Orders usually ship within 24 hours of payment, so it keeps a considerable inventory of raw materials and finished goods.

Its biggest risks, as it describes them

  • Direct selling laws that could restrict or force changes to how it sells in some countries.
  • Failing to attract and keep independent consultants, or losing key ones with large sales networks.
  • Strict government rules on its products, and difficulty registering them for sale abroad.
  • Product liability claims, and obligations arising from what its consultants do.
  • Currency swings, and supply chain or manufacturing interruptions.
From Nature's Sunshine Products's annual report on Form 10-K, filed March 10, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2025, earnings per share grew 28.6% a year and net income 44.7% a year, as buybacks cut the share count by 3%.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments8660828594
Debt incl. finance leases21000
Net debt (negative means net cash)−84−59−82−85−94
Net debt to EBITDA−1.8x−2.2x−2.7x−2.5x−2.4x
Debt to equity0.0x0.0x0.0x0.0x0.0x
Interest coverage138.7x65.3x271.7x137.6x252.5x
Current ratio2.1x2.3x2.2x2.4x2.3x
Quick ratio1.4x1.2x1.3x1.5x1.4x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Nature's Sunshine Products' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What Nature's Sunshine Products says to expect

  • Full year 2026: net sales and adjusted EBITDAReflecting the impact of a stronger U.S. dollar and recent challenges in the China market, Nature's Sunshine now expects full year 2026 net sales to range between $460 and $470 million ($490 and $500 million prior). Adjusted EBITDA is now expected to range between $44 and $48 million ($48 and $52 million prior).
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed November 4, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

Over the 12 months between November 14, 2025 and November 13, 2026, 2 insiders bought $5.5 million of Nature's Sunshine Products shares on the open market, and 5 insiders sold $1.9 million.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Nov 5, 2026Prescott Group Capital Management L.l.c.10% ownerBought291,666$9.77$2.8 millionForm 4
Aug 17, 2026Phil Frohlich10% ownerBought20,000$14.69$293,800Form 4
Aug 10, 2026Prescott Group Capital Management L.l.c.10% ownerBought40,876$15.84$647,539Form 4
Aug 7, 2026Prescott Group Capital Management L.l.c.10% ownerBought96,000$16.63$1.6 millionForm 4
Aug 6, 2026Prescott Group Capital Management L.l.c.10% ownerBought4,513$16.57$74,793Form 4
Jun 12, 2026Kevin R. HerbertEVP & President, North AmericaSold2,000$20.68$41,364Form 4
Jun 5, 2026Bryant J YatesEVP & President, EuropeSold11,968$19.90$238,163Form 4
Jun 1, 2026Daniel C NormanEVP & President, AsiaSold9,713$20.64$200,476Form 4
May 21, 2026Nathan G BrowerEVP, General CounselSold12,015$21.84$262,408Form 4
Mar 13, 2026Bryant J YatesEVP & President, EuropeSold19,516$24.35$475,215Form 4
Mar 13, 2026Daniel C NormanEVP & President, AsiaSold15,383$24.52$377,191Form 4
Mar 13, 2026Jonathan David LanoySVP, Chief Accounting OfficerSold4,000$24.70$98,800Form 4
The latest 12 of 15 trades. Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score7 of 95 of 97 of 9
Rule of 4012.4%5.2%11.7%
Altman Z''5.356.045.82
Accruals ratio−10.9%−7.2%−6.3%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets rosePassFailPass
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassFailFail
Current ratio roseFailPassFail
Share count didn't riseFailPassPass
Gross margin rosePassFailPass
Revenue rose relative to assetsPassFailPass
F-score7 of 95 of 97 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Nature's Sunshine Products side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
Nature's Sunshine ProductsFY255.7%5.2%6.0%23.6%−2.4x7
The Honest CompanyFY25−1.9%−5.0%3.7%———Compare
USANA Health SciencesFY258.3%4.0%0.9%———Compare
Nu SkinFY25−14.3%4.4%3.1%6.5%−0.1x7Compare
e.l.f. BeautyFY2624.6%4.5%11.6%3.8%3.6x4Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue341342365362385444422445454480
Revenue growth5.1%0.3%6.7%−0.7%6.3%15.3%−5.0%5.5%2.0%5.7%
Gross profit250251269268284329300321325348
Research and development3332212222
Operating income101516223516192025
Net income1−14−172330−015820
Diluted EPS (US$)0.11−0.69−0.040.341.071.42−0.020.770.401.06
Diluted shares (millions)19191920202019201918
Cash flow
Cash from operations31022838351412535
Capital expenditure1165557810116
Free cash flow−851733328−7311429
Dividends paid82000200000
Share buybacks000007146916
Acquisitions0000000000
Stock-based compensation3222443556
Balance sheet at fiscal year end
Cash and short-term investments32435154928660828594
Debt incl. finance leases———0421000
Total assets206195193213250259230250241261
Total liabilities737672849298839080100
Shareholders' equity132120121129157161147160161162
Margins and ratios
Gross margin73.3%73.4%73.8%74.1%73.7%74.0%71.0%72.1%71.5%72.4%
Operating margin2.9%0.4%1.5%4.5%5.6%7.8%3.9%4.2%4.4%5.2%
Net margin0.2%−4.0%−0.3%1.9%6.0%6.8%−0.1%3.4%1.7%4.1%
Free cash flow margin−2.2%1.5%4.7%0.9%8.5%6.3%−1.6%6.9%3.1%6.0%
Rule of 40 (growth + FCF margin)2.8%1.7%11.3%0.2%14.8%21.6%−6.6%12.4%5.2%11.7%
Return on capital————29.7%44.9%9.8%18.4%13.1%23.6%
Return on equity0.5%−11.0%−1.0%5.5%16.0%19.0%−0.2%9.8%4.8%12.1%
Return on assets0.3%−6.9%−0.6%3.4%9.9%11.9%−0.2%6.3%3.1%7.8%
Net debt to EBITDA———−2.0x−2.7x−1.8x−2.2x−2.7x−2.5x−2.4x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Nature's Sunshine Products' Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Nature's Sunshine Products.